← BackBrowse analysis archive →
Bayer's KERENDIA (finerenone) Wins FDA Nod as First New CKD Treatment in Type 1 Diabetes in 30 Years
Business Wire · 57d ago · Sentiment +0.35
Read original ↗Impact scope
2 industries
direct 2·2nd-order 2
Top gainer
🔒
Top loser
🔒
Impact chainNews → industry → company, ranked top-down by impact
Pro only
Impact chains, crowding, market view and insider signals — try Pro free for 7 days when you sign up.
Start my free trial